A comparative review of marketing authorisation decisions in Switzerland, the EU, and the USA

19 April 2018 - In this study we compared Swissmedic’s regulatory marketing authorisation decisions to those of the US FDA ...

Read more →

FDA approves drugs before EMA and Swissmedic, comparison finds

23 February 2018 - From 2007 to 2016, the US FDA approved more new drugs and biologics first than its ...

Read more →